HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE ORAL SOLUTION

HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE ORAL SOLUTION was reported 0 times

These side effects are most commonly reported by patients taking HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE ORAL SOLUTION:

# Side effect Count
0 ABDOMINAL PAIN UPPER 3
1 CONSTIPATION 3
2 DECREASED APPETITE 3
3 DIZZINESS 3
4 HYPERSENSITIVITY 3
5 INJECTION SITE RASH 3
6 NAUSEA 3
7 ADVERSE DRUG REACTION 2
8 CHRONIC KIDNEY DISEASE 2
9 DIARRHOEA 2
10 HEADACHE 2
11 PAIN 2
12 SOMNOLENCE 2
13 VOMITING 2
14 ABNORMAL DREAMS 1
15 AGEUSIA 1
16 ATAXIA 1
17 BACK DISORDER 1
18 BLISTER 1
19 BLOOD CHOLESTEROL INCREASED 1
20 BURKHOLDERIA TEST POSITIVE 1
21 CARDIAC FAILURE CONGESTIVE 1
22 CARDIOMYOPATHY 1
23 CELLULITIS 1
24 CONDITION AGGRAVATED 1
25 COVID-19 1
26 DEATH 1
27 DRUG EFFECT DECREASED 1
28 DRUG INEFFECTIVE 1
29 DRY EYE 1
30 DYSKINESIA 1
31 ENDOTRACHEAL INTUBATION 1
32 FALL 1
33 FATIGUE 1
34 GAIT DISTURBANCE 1
35 GAIT INABILITY 1
36 GASTROENTERITIS VIRAL 1
37 HAEMORRHAGE URINARY TRACT 1
38 HAIR COLOUR CHANGES 1
39 HALLUCINATION 1
40 HIP ARTHROPLASTY 1
41 HYPOAESTHESIA 1
42 IMPAIRED DRIVING ABILITY 1
43 INCORRECT DOSE ADMINISTERED 1
44 INCORRECT PRODUCT ADMINISTRATION DURATION 1
45 INFLUENZA 1
46 INJECTION SITE ERYTHEMA 1
47 INJECTION SITE WARMTH 1
48 INTENTIONAL DOSE OMISSION 1
49 INTERCEPTED PRODUCT DISPENSING ERROR 1
50 MALAISE 1
51 MOBILITY DECREASED 1
52 MULTIPLE SCLEROSIS 1
53 OFF LABEL USE 1
54 PLASMA CELL MYELOMA 1
55 PLATELET COUNT DECREASED 1
56 PNEUMONIA 1
57 PRODUCT APPEARANCE CONFUSION 1
58 PRODUCT DOSE OMISSION ISSUE 1
59 PRODUCT LABEL CONFUSION 1
60 RESPIRATORY FAILURE 1
61 RESPIRATORY RATE DECREASED 1
62 RHEUMATOID ARTHRITIS 1
63 SKIN DISCOLOURATION 1
64 SYNCOPE 1
65 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 1
66 THERAPY CESSATION 1
67 THERAPY INTERRUPTED 1
68 UNEVALUABLE EVENT 1
69 WEIGHT DECREASED 1
70 WITHDRAWAL SYNDROME 1